id	sid	eid	entity	type
gs-3903	1	1	microsoft	ORG
gs-3903	1	2	fullpdf07032025 georgian scientists/ქართველი	ORG
gs-3903	1	3	მეცნიერები	GPE
gs-3903	1	4	7	CARDINAL
gs-3903	1	5	57	CARDINAL
gs-3903	1	6	georgian	NORP
gs-3903	1	7	მეცნიერები	GPE
gs-3903	1	8	7	CARDINAL
gs-3903	1	9	3	CARDINAL
gs-3903	2	1	khachidze¹,²	GPE
gs-3903	2	2	gela sulaberidze¹	PERSON
gs-3903	2	3	1tbilisi	CARDINAL
gs-3903	2	4	state medical university	ORG
gs-3903	2	5	00033411-4682	DATE
gs-3903	2	6	2tbilisi	CARDINAL
gs-3903	2	7	3tbilisi	CARDINAL
gs-3903	7	1	85	CARDINAL
gs-3903	8	1	12 weeks	DATE
gs-3903	9	1	lfts	PERSON
gs-3903	10	1	12 weeks	DATE
gs-3903	10	2	18.5	CARDINAL
gs-3903	10	3	12.3	CARDINAL
gs-3903	10	4	15.2	CARDINAL
gs-3903	11	1	64.7%	PERCENT
gs-3903	11	2	at least one	CARDINAL
gs-3903	14	1	georgian	NORP
gs-3903	14	2	მეცნიერები	GPE
gs-3903	14	3	7	CARDINAL
gs-3903	14	4	3	CARDINAL
gs-3903	14	5	58	CARDINAL
gs-3903	14	6	more than 5%	PERCENT
gs-3903	15	1	masld	PERSON
gs-3903	16	1	17	CARDINAL
gs-3903	18	1	about one-third	CARDINAL
gs-3903	18	2	17	CARDINAL
gs-3903	20	1	2	CARDINAL
gs-3903	21	1	masld	PERSON
gs-3903	23	1	6,7	CARDINAL
gs-3903	25	1	around 75%	PERCENT
gs-3903	25	2	10	CARDINAL
gs-3903	28	1	11,12	CARDINAL
gs-3903	29	1	10,11,12	CARDINAL
gs-3903	30	1	approximately 1,000 to 1,500	CARDINAL
gs-3903	30	2	between 10 and 100 trillion	CARDINAL
gs-3903	30	3	about ten	CARDINAL
gs-3903	31	1	two	CARDINAL
gs-3903	32	1	11	CARDINAL
gs-3903	34	1	gram	CARDINAL
gs-3903	35	1	georgian	NORP
gs-3903	35	2	მეცნიერები	GPE
gs-3903	35	3	7	CARDINAL
gs-3903	35	4	e. coli	PERSON
gs-3903	36	1	4,5	CARDINAL
gs-3903	37	1	4,5	CARDINAL
gs-3903	38	1	5,6	CARDINAL
gs-3903	43	1	18,19	CARDINAL
gs-3903	44	1	6,19	CARDINAL
gs-3903	46	1	6,7,8	CARDINAL
gs-3903	51	1	15	CARDINAL
gs-3903	53	1	2,3,15,20	CARDINAL
gs-3903	54	1	2,3	CARDINAL
gs-3903	55	1	gram	CARDINAL
gs-3903	57	1	10,11	CARDINAL
gs-3903	59	1	6,8	CARDINAL
gs-3903	60	1	crp	ORG
gs-3903	60	2	2,12,16	CARDINAL
gs-3903	61	1	georgian	NORP
gs-3903	61	2	მეცნიერები	GPE
gs-3903	61	3	7	CARDINAL
gs-3903	61	4	60	CARDINAL
gs-3903	61	5	18	CARDINAL
gs-3903	61	6	2	CARDINAL
gs-3903	62	1	16	CARDINAL
gs-3903	63	1	21,22	CARDINAL
gs-3903	65	1	3,15	CARDINAL
gs-3903	67	1	85	CARDINAL
gs-3903	67	2	8.7 years	DATE
gs-3903	67	3	54%	PERCENT
gs-3903	67	4	three	CARDINAL
gs-3903	67	5	tbilisi state medical university	ORG
gs-3903	67	6	between january and november 2024	DATE
gs-3903	68	1	georgian	NORP
gs-3903	68	2	მეცნიერები	GPE
gs-3903	68	3	7	CARDINAL
gs-3903	70	1		CARDINAL
gs-3903	70	2	2	CARDINAL
gs-3903	72	1	82	CARDINAL
gs-3903	72	2	1 billion	CARDINAL
gs-3903	72	3	3	CARDINAL
gs-3903	72	4	1 billion	CARDINAL
gs-3903	73	1	bulgaricus	ORG
gs-3903	73	2	5 1 billion	MONEY
gs-3903	74	1	1 billion	CARDINAL
gs-3903	74	2	dsm 8716	ORG
gs-3903	74	3	1 1 billion	MONEY
gs-3903	74	4	sp4	NORP
gs-3903	74	5	1 1 billion	MONEY
gs-3903	74	6		CARDINAL
gs-3903	74	7	5	CARDINAL
gs-3903	74	8	+ 5	CARDINAL
gs-3903	74	9	daily	DATE
gs-3903	74	10	12 weeks	DATE
gs-3903	75	1	at least 30–45 min	CARDINAL
gs-3903	75	2	at least 5 days	DATE
gs-3903	75	3	a week	DATE
gs-3903	76	1	5%–10%	PERCENT
gs-3903	76	2	more than 1.6 kg	QUANTITY
gs-3903	76	3	30%	PERCENT
gs-3903	77	1	 age 18–70	DATE
gs-3903	77	2	masld	PERSON
gs-3903	77	3		CARDINAL
gs-3903	77	4	prior 6 weeks	DATE
gs-3903	77	5		CARDINAL
gs-3903	77	6	40g/week	DATE
gs-3903	77	7		CARDINAL
gs-3903	77	8	8 weeks	DATE
gs-3903	80	1	georgian	NORP
gs-3903	80	2	მეცნიერები	GPE
gs-3903	80	3	7	CARDINAL
gs-3903	80	4		CARDINAL
gs-3903	80	5	29.8 ±	MONEY
gs-3903	80	6	3.4 kg	QUANTITY
gs-3903	80	7	58.7 ±	MONEY
gs-3903	80	8	14.5	CARDINAL
gs-3903	80	9	u/l	EVENT
gs-3903	80	10	42.1 ±	MONEY
gs-3903	80	11	u/l	ORG
gs-3903	80	12	76.3 ±	CARDINAL
gs-3903	80	13	23.4	CARDINAL
gs-3903	80	14	u/l	ORG
gs-3903	80	15	1	CARDINAL
gs-3903	80	16	lft	ORG
gs-3903	80	17	±	CARDINAL
gs-3903	80	18	±	CARDINAL
gs-3903	80	19	u/l	EVENT
gs-3903	80	20	58.7	CARDINAL
gs-3903	80	21	40.2 ±	QUANTITY
gs-3903	80	22	18.5	CARDINAL
gs-3903	80	23	u/l	EVENT
gs-3903	80	24	42.1	CARDINAL
gs-3903	80	25	29.8 ±	QUANTITY
gs-3903	80	26	12.3 0.002	CARDINAL
gs-3903	80	27	u/l	ORG
gs-3903	80	28	76.3	CARDINAL
gs-3903	80	29	61.1 ±	QUANTITY
gs-3903	80	30	15.2 0.005 %	PERCENT
gs-3903	80	31	at least 1	CARDINAL
gs-3903	80	32	64.7%	PERCENT
gs-3903	80	33	8.2%	PERCENT
gs-3903	80	34		CARDINAL
gs-3903	80	35	55	CARDINAL
gs-3903	80	36	64.7%	PERCENT
gs-3903	80	37	at least one	CARDINAL
gs-3903	80	38	lft	ORG
gs-3903	80	39	lft	ORG
gs-3903	80	40		CARDINAL
gs-3903	80	41	8.2%	PERCENT
gs-3903	80	42		CARDINAL
gs-3903	82	1		CARDINAL
gs-3903	83	1	2,3,6,8,10	CARDINAL
gs-3903	83	2		CARDINAL
gs-3903	83	3	10,11,12	CARDINAL
gs-3903	83	4	1	CARDINAL
gs-3903	83	5	3,6,13,15,20	CARDINAL
gs-3903	85	1	georgian	NORP
gs-3903	85	2	მეცნიერები	GPE
gs-3903	85	3	7	CARDINAL
gs-3903	87	1	2,3,14	CARDINAL
gs-3903	88	1	12-week	DATE
gs-3903	91	1	1	CARDINAL
gs-3903	91	2	alisi	GPE
gs-3903	95	1	2014;103(1):18–27	CARDINAL
gs-3903	96	1	2	CARDINAL
gs-3903	96	2	ma yy	PERSON
gs-3903	97	1	j gastroenterol	PERSON
gs-3903	99	1	3	CARDINAL
gs-3903	100	1	zhu l	PERSON
gs-3903	101	1	clin nutr	ORG
gs-3903	102	1	2022;41(1):225–234	CARDINAL
gs-3903	102	2	4	CARDINAL
gs-3903	102	3	roy t	PERSON
gs-3903	104	1	2019;29(4):875–882	CARDINAL
gs-3903	104	2	5	CARDINAL
gs-3903	104	3	boursier j	PERSON
gs-3903	107	1	2016;63(3):764–775	CARDINAL
gs-3903	108	1	6	CARDINAL
gs-3903	108	2	aron-wisnewsky j	PERSON
gs-3903	110	1	nat rev gastroenterol hepatol	PERSON
gs-3903	111	1	2020;17(5):279–297	CARDINAL
gs-3903	111	2	7	CARDINAL
gs-3903	111	3	tilg	PERSON
gs-3903	113	1	nat rev gastroenterol hepatol	PERSON
gs-3903	114	1	2021;18(7):497–515	CARDINAL
gs-3903	115	1	gerard p.	PERSON
gs-3903	117	1	2019;76(8):1541–1558	CARDINAL
gs-3903	118	1	9	CARDINAL
gs-3903	118	2	de minicis s	PERSON
gs-3903	120	1	2014;59(5):1738–1749	CARDINAL
gs-3903	121	1	10	CARDINAL
gs-3903	122	1	jiang w	PERSON
gs-3903	123	1	sci rep	ORG
gs-3903	123	2	2015;5:8096	CARDINAL
gs-3903	124	1	11	CARDINAL
gs-3903	125	1	miele l	PERSON
gs-3903	128	1	georgian	NORP
gs-3903	128	2	მეცნიერები	GPE
gs-3903	128	3	7	CARDINAL
gs-3903	128	4	64 12	CARDINAL
gs-3903	129	1	chiu cn	PERSON
gs-3903	131	1	clin	PERSON
gs-3903	132	1	2021;45(4):101626	CARDINAL
gs-3903	132	2	13	CARDINAL
gs-3903	133	1	shen	PERSON
gs-3903	137	1	2017;16(4):375–381	CARDINAL
gs-3903	138	1	14	CARDINAL
gs-3903	138	2	del chierico	PERSON
gs-3903	141	1	2017;65(2):451–464	CARDINAL
gs-3903	142	1	15	CARDINAL
gs-3903	142	2	l	DATE
gs-3903	144	1	curr pharm des.	ORG
gs-3903	144	2	2020;26(30):3632–3637	CARDINAL
gs-3903	145	1	16	CARDINAL
gs-3903	146	1	salazar n	PERSON
gs-3903	148	1	j clin nutr	PERSON
gs-3903	149	1	2011;93(4):622–631	CARDINAL
gs-3903	150	1	17	CARDINAL
gs-3903	151	1	eslam m	ORG
gs-3903	153	1	j hepatol	PERSON
gs-3903	154	1	2020;73(1):202	CARDINAL
gs-3903	154	2	209	CARDINAL
gs-3903	155	1	18	CARDINAL
gs-3903	158	1	j gastroenterol hepatol	PERSON
gs-3903	160	1	19	CARDINAL
gs-3903	160	2	machado mv	PERSON
gs-3903	160	3	h. diet	PERSON
gs-3903	162	1	2014;5(4):409–415	CARDINAL
gs-3903	163	1	kobyliak n	PERSON
gs-3903	164	1	crit rev	ORG
gs-3903	164	2	sci nutr	ORG
gs-3903	165	1	2018;58(4):640–657	CARDINAL
gs-3903	166	1	21	CARDINAL
gs-3903	167	1	malaguarnera m	PERSON
gs-3903	168	1	dis sci	PERSON
gs-3903	169	1	2012;57(2):545–553	CARDINAL
gs-3903	170	1	qin	PERSON
gs-3903	174	1	2014;513(7516):59–64	CARDINAL
gs-3903	175	1	23	CARDINAL
gs-3903	176	1	wong vw	PERSON
gs-3903	178	1	nat rev gastroenterol hepatol.	PERSON
gs-3903	179	1	2015;12(7):388–400	CARDINAL
gs-3903	179	2	24	CARDINAL
gs-3903	184	1	georgian	NORP
gs-3903	184	2	მეცნიერები	GPE
gs-3903	184	3	7	CARDINAL
gs-3903	184	4	65	CARDINAL
gs-3903	184	5	მართვაში	TIME
gs-3903	184	6	კლინიკური პერსპექტივა თათია ხაჩიძე	PERSON
gs-3903	184	7	გელა სულაბერიძე	ORG
gs-3903	184	8	გოჩა ბარბაქაძე	ORG
gs-3903	184	9	სტეატოზური დაავადება	PERSON
gs-3903	184	10	ციროზში	PERSON
gs-3903	184	11	როლს	ORG
gs-3903	185	1	masld-ის მქონე	GPE
gs-3903	185	2	გამომდინარე ნაწლავის	GPE
gs-3903	185	3	თერაპიის კლინიკური	GPE
gs-3903	185	4	გავლენა	GPE
gs-3903	185	5	masld-ის მქონე	GPE
gs-3903	185	6	კვლევაში ჩართული	PERSON
gs-3903	185	7	85	DATE
gs-3903	185	8	მონაწილეები	GPE
gs-3903	185	9	სტანდარტიზებულ კომბინაციას 12	PERSON
gs-3903	185	10	კვირის	ORG
gs-3903	185	11	შემდეგ. შედეგები:	ORG
gs-3903	185	12	12	CARDINAL
gs-3903	187	1	18.5	CARDINAL
gs-3903	187	2	12.3 u/l, p=0.002	PERCENT
gs-3903	187	3	15.2 u/l	PERCENT
gs-3903	189	1	64.7%-მა	CARDINAL
gs-3903	189	2	კვლევამ აჩვენა	PERSON
gs-3903	189	3	აუმჯობესებს	PERSON
gs-3903	189	4	masld-ის	LANGUAGE
gs-3903	189	5	მოდულაციის	ORG
gs-3903	189	6	masld-ის მართვაში.	TIME
gs-3903	189	7	საკვანძო	ORG
gs-3903	189	8	სტეატოზური დაავადება	GPE
gs-3903	189	9	პრობიოტიკები	GPE
gs-3903	189	10	პრებიოტიკენი	ORG